OFIX (Orthofix Medical Inc.) Stock Financials & Earnings

OFIXOrthofix Medical Inc.

Mkt Cap$503M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$822M

Net Income (TTM)-$92M

EPS (TTM)-$2.34

Free Cash Flow (TTM)-$11M

Gross Margin67.1%

Op. Margin-8.3%

Net Margin-11.2%

FCF Margin-1.3%

P/S Ratio (TTM)0.6x

P/E Ratio (TTM)—

YoY Rev Growth+2.9%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$175M	$110M	-$60M
Q2 23	$187M	$120M	-$37M
Q3 23	$184M	$120M	-$24M
Q4 23	$200M	$137M	-$18M
Q1 24	$189M	$127M	-$29M
Q2 24	$199M	$135M	-$25M
Q3 24	$197M	$135M	-$19M
Q4 24	$216M	$149M	-$11M
Q1 25	$194M	$122M	-$49M
Q2 25	$203M	$140M	-$16M
Q3 25	$206M	$149M	-$17M
Q4 25	$220M	$142M	$13M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$23M	$49M	$94M	—
Q2 23	$19M	$34M	$99M	—
Q3 23	$19M	$27M	$95M	—
Q4 23	$19M	$35M	$98M	—
Q1 24	$19M	$32M	$100M	—
Q2 24	$18M	$34M	$100M	—
Q3 24	$17M	$34M	$97M	—
Q4 24	$19M	—	—	$136M
Q1 25	$20M	—	—	$133M
Q2 25	$16M	—	—	$136M
Q3 25	$15M	—	—	$148M
Q4 25	$15M	—	—	$137M

Revenue Segments

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$50M	$0	$50M
Q2 23	$38M	$0	$38M
Q3 23	$34M	$0	$34M
Q4 23	$33M	$0	$33M
Q1 24	$27M	$0	$27M
Q2 24	$26M	$0	$26M
Q3 24	$30M	$0	$30M
Q4 24	$83M	$0	$83M
Q1 25	$58M	$0	$58M
Q2 25	$66M	$0	$66M
Q3 25	$66M	$0	$66M
Q4 25	$82M	$0	$82M

Shares Outstanding

Revenue Per Employee

Revenue / Employee